New pill targets genetic driver in Tough-to-Treat liver cancer
NCT ID NCT07328919
Summary
This study is for adults with advanced bile duct cancer that has a specific genetic change (FGFR2) and has worsened after initial treatment. It compares a new targeted pill called TT-00420 to standard chemotherapy to see which is better at controlling the cancer and is safer. The goal is to find a more effective treatment for people who have run out of good options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
Hefei, Anhui, China
-
Beijing Cancer Hospital
Beijing, China
Contact
-
Beijing Tsinghua Changgung Hospital
Beijing, China
-
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China
-
Eastern Hepatobiliary Surgery Hospital
Shanghai, China
-
Fudan University Shanghai Cancer Hospital
Shanghai, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, China
-
Hunan Cancer Hospital
Changsha, Hunan, China
-
Jinan Central Hospital
Jinan, Shandong, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
-
Peking Union Medical College Hospital
Beijing, China
-
Shandong Cancer Hospital
Jinan, Shandong, China
-
Sichuan Cancer Hospital
Chengdu, Sichuan, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
-
Zhongnan hospital of Wuhan University
Wuhan, Hubei, China
-
Zhongshan Hospital, Fudan University
Shanghai, China
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.